18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.

NCT05983796 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

First Affiliated Hospital of Zhejiang University